Literature DB >> 8805871

Epidemiological surveillance of leishmaniasis in HIV-1-infected individuals in Italy.

L Gradoni1, A Scalone, M Gramiccia, M Troiani.   

Abstract

OBJECTIVE: To actively detect leishmaniasis in HIV-1-infected individuals in Italy, to describe the epidemiological features of the disease in these patients, and to compare them with epidemiological features of leishmaniasis in HIV-negative patients.
DESIGN: Retrospective and prospective surveillance study. PATIENTS: Italian patients with HIV-1 infection and leishmaniasis diagnosed between 1985 and 1994.
RESULTS: We recorded 116 leishmaniasis cases (115 visceral leishmaniasis), of which 94 (81%) were diagnosed over the last 4 years. Seventy-eight patients (67%) fulfilled the 1993 Centers for Disease Control and Prevention AIDS criteria. Leishmaniasis was passively reported in only 18% of cases. Leishmania incidence estimated among approximately 2700 AIDS patients living in leishmaniasis endemic areas averaged 1.6%, with a maximum of 4.9% in Sicily. These rates were up to 500-fold higher than among HIV-negative individuals living in the same areas, and were similar to those of ubiquitous opportunistic agents indicative of AIDS condition. Data from two major endemic regions indicated that overlap of HIV-1 and Leishmania infections has focal characteristics. The occurrence of small case clusters would suggest occasional modes of Leishmania transmission different from the insect vector. The isoenzyme characterization of 38 Leishmania stocks showed a zymodeme spectrum qualitatively and quantitatively different from that of the parasitic agent of visceral leishmaniasis in HIV-negative adults.
CONCLUSIONS: Active surveillance provided reliable evaluation on the occurrence of HIV-Leishmania coinfections in Italy, although it was limited to hospital-based cases in this study due to general under-reporting of cases. Biological and epidemiological spectrum of the disease suggests that visceral leishmaniasis should be included among AIDS-defining pathologies.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8805871     DOI: 10.1097/00002030-199606001-00014

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  22 in total

1.  Noninvasive method for diagnosis of visceral leishmaniasis by a latex agglutination test for detection of antigens in urine samples.

Authors:  C Vilaplana; S Blanco; J Domínguez; M Giménez; V Ausina; Cristina TUral; Carme Muñoz
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

2.  AIDS and leishmaniasis.

Authors:  R N Davidson
Journal:  Genitourin Med       Date:  1997-08

Review 3.  Recent developments in drug discovery for leishmaniasis and human African trypanosomiasis.

Authors:  Advait S Nagle; Shilpi Khare; Arun Babu Kumar; Frantisek Supek; Andriy Buchynskyy; Casey J N Mathison; Naveen Kumar Chennamaneni; Nagendar Pendem; Frederick S Buckner; Michael H Gelb; Valentina Molteni
Journal:  Chem Rev       Date:  2014-11-03       Impact factor: 60.622

4.  Mediterranean leishmaniasis in HIV-infected patients: epidemiological, clinical, and diagnostic features of 22 cases.

Authors:  C Agostoni; N Dorigoni; A Malfitano; L Caggese; G Marchetti; S Corona; S Gatti; M Scaglia
Journal:  Infection       Date:  1998 Mar-Apr       Impact factor: 3.553

5.  Incidence of and risk factors for symptomatic visceral leishmaniasis among human immunodeficiency virus type 1-infected patients from Spain in the era of highly active antiretroviral therapy.

Authors:  Rafael de La Rosa; Juan A Pineda; Juan Delgado; Juan Macías; Francisco Morillas; José A Mira; Armando Sánchez-Quijano; Manuel Leal; Eduardo Lissen
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

6.  Prevalence of and factors associated with visceral leishmaniasis in human immunodeficiency virus type 1-infected patients in southern Spain.

Authors:  J A Pineda; J A Gallardo; J Macías; J Delgado; C Regordán; F Morillas; F Relimpio; J Martín-Sánchez; A Sánchez-Quijano; M Leal; E Lissen
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

7.  Asymptomatic Leishmania infantum infection in an area of northwestern Italy (Piedmont region) where such infections are traditionally nonendemic.

Authors:  Alberto Biglino; Cesare Bolla; Erika Concialdi; Anna Trisciuoglio; Angelo Romano; Ezio Ferroglio
Journal:  J Clin Microbiol       Date:  2009-11-18       Impact factor: 5.948

8.  Visceral leishmaniasis revealed by a squamous cell carcinoma in an HIV-1 infected patient.

Authors:  P Donati; G Paolino; C Panetta; L Muscardin; C Cota; M Giuliani
Journal:  Infection       Date:  2013-02-03       Impact factor: 3.553

Review 9.  Practical guide for the treatment of leishmaniasis.

Authors:  R N Davidson
Journal:  Drugs       Date:  1998-12       Impact factor: 9.546

Review 10.  The relationship between leishmaniasis and AIDS: the second 10 years.

Authors:  Jorge Alvar; Pilar Aparicio; Abraham Aseffa; Margriet Den Boer; Carmen Cañavate; Jean-Pierre Dedet; Luigi Gradoni; Rachel Ter Horst; Rogelio López-Vélez; Javier Moreno
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.